BioNTech SE (BNTX) insider trading.
In Q3 2026, insiders at BioNTech SE reported 19 non-derivative transactions on 10 Forms 3, 4 and 5: 0 open-market purchases and 19 sales worth $63.7M.
- Transactions
- 19
- Purchases (P)
- 0
- Sales (S)
- 19
- Net shares, P minus S
- -644,000
- Insiders
- 1
- Last filed
- 2026-09-30
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Sahin Ugur | Officer, TenPercentOwner · Chief Executive Officer | 19 | 0 | 19 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-30 | Sahin Ugur | S (D) | 32,000 | $98.12 | 214,209 | Form 4 |
| 2026-09-29 | Sahin Ugur | S (D) | 34,000 | $98.26 | 246,209 | Form 4 |
| 2026-09-28 | Sahin Ugur | S (D) | 34,000 | $98.47 | 280,209 | Form 4 |
| 2026-09-25 | Sahin Ugur | S (D) | 27,000 | $98.69 | 314,209 | Form 4 |
| 2026-09-24 | Sahin Ugur | S (D) | 39,000 | $98.99 | 341,209 | Form 4 |
| 2026-09-23 | Sahin Ugur | S (D) | 30,000 | $99.4 | 380,209 | Form 4 |
| 2026-09-22 | Sahin Ugur | S (D) | 46,000 | $100.72 | 410,209 | Form 4 |
| 2026-09-21 | Sahin Ugur | S (D) | 33,000 | $97.81 | 456,209 | Form 4 |
| 2026-09-18 | Sahin Ugur | S (D) | 30,000 | $96.22 | 489,209 | Form 4 |
| 2026-09-17 | Sahin Ugur | S (D) | 34,000 | $98.6 | 519,209 | Form 4 |
| 2026-09-16 | Sahin Ugur | S (D) | 15,000 | $96.09 | 553,209 | Form 4 |
| 2026-09-15 | Sahin Ugur | S (D) | 34,000 | $96.49 | 568,209 | Form 4 |
| 2026-09-14 | Sahin Ugur | S (D) | 41,000 | $99.45 | 602,209 | Form 4 |
| 2026-09-11 | Sahin Ugur | S (D) | 45,000 | $96.93 | 643,209 | Form 4 |
| 2026-09-10 | Sahin Ugur | S (D) | 20,500 | $96.31 | 688,209 | Form 4 |
| 2026-09-09 | Sahin Ugur | S (D) | 36,000 | $97.78 | 708,709 | Form 4 |
| 2026-09-08 | Sahin Ugur | S (D) | 37,000 | $99.2 | 744,709 | Form 4 |
| 2026-09-04 | Sahin Ugur | S (D) | 31,500 | $103.52 | 781,709 | Form 4 |
| 2026-09-03 | Sahin Ugur | S (D) | 45,000 | $102.85 | 813,209 | Form 4 |
Transaction codes in this quarter
Get BNTX insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1776985&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · BNTX company page · BioNTech SE on SEC.gov
Questions
Are insiders buying or selling BioNTech SE (BNTX)?
In Q3 2026, insiders at BioNTech SE reported 19 non-derivative transactions on 10 Forms 3, 4 and 5: 0 open-market purchases and 19 sales worth $63.7M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these BioNTech SE insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/bntx.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.